COX-2 inhibitors: a role in Alzheimer's disease?
McGahan
L
L
Canadian Coordinating Office for Health Technology Assessment. lyndam@ccohta.ca
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D002170:Canada; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000191:economics / Q000627:therapeutic use*; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D007783:Lactones; D013449:Sulfonamides